A Combination of Glucagon-Like Peptide-1 Receptor Agonist and Dietary Intervention Could Be a Promising Approach for Obesity Treatment

Front Endocrinol (Lausanne). 2021 Sep 20:12:748477. doi: 10.3389/fendo.2021.748477. eCollection 2021.
No abstract available

Keywords: combination therapy; diet; glucagon-like peptide-1 agonist; gut-brain axis; obesity.

Publication types

  • Review

MeSH terms

  • Combined Modality Therapy
  • Glucagon-Like Peptide-1 Receptor / agonists*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Obesity / diet therapy
  • Obesity / drug therapy
  • Obesity / therapy*
  • Treatment Outcome

Substances

  • Glucagon-Like Peptide-1 Receptor
  • Hypoglycemic Agents